Complex APC2*:CK1_epsilon_*:CTHRC1:DAAM1:DVL*:FZD*:GSK3*:PAR6*:RACK1*:ROR2:RSPO3:SYN4*:VANGL*:WGEF*:WNT*:_beta_-Arrestin2* map
Complex composition:

  1. FZD* map
  2. WNT* map
  3. CK1_epsilon_* map
  4. DVL* map
  5. APC2* map
  6. GSK3* map
  7. CTHRC1 map
  8. SYN4* map
  9. _beta_-Arrestin2* map
  10. VANGL* map
  11. RACK1* map
  12. ROR2 map
  13. PAR6* map
  14. RSPO3 map
  15. WGEF* map
  16. DAAM1 map

APC2*:​CK1_epsilon_*:​CTHRC1:​DAAM1:​DVL*|​pho|​S142_pho|​S139_pho:​FZD*:​GSK3*:​PAR6*:​RACK1*:​ROR2|​S864_pho|​pho|​pho:​RSPO3:​SYN4*:​VANGL*|​pho|​pho|​pho|​pho:​WGEF*:​WNT*:​_beta_-Arrestin2*@Cytoplasm

Identifiers
NAME:APC2*:CK1_epsilon_*:CTHRC1:DAAM1:DVL*:FZD*:GSK3*:PAR6*:RACK1*:ROR2:RSPO3:SYN4*:VANGL*:WGEF*:WNT*:_beta_-Arrestin2*

References
PCP MODULE
s_wnc1_re146:( Survival  map ) Not sure if Rho dissociates when active
s_wnc1_re143( Survival  map ):
Activated Daam1 is responisble for the inhibition
PMID:20351293
Referenes_end

Modifications:
Participates in complexes:
In compartment: Cytoplasm
  1. APC2*:​CK1_epsilon_*:​CTHRC1:​DAAM1:​DVL*|​pho|​S142_pho|​S139_pho:​FZD*:​GSK3*:​PAR6*:​RACK1*:​ROR2|​S864_pho|​pho|​pho:​RSPO3:​SYN4*:​VANGL*|​pho|​pho|​pho|​pho:​WGEF*:​WNT*:​_beta_-Arrestin2*@Cytoplasm map
Participates in reactions:
As Reactant or Product:
  1. APC2*:​CK1_epsilon_*:​CTHRC1:​DAAM1:​DVL*|​pho|​S142_pho|​S139_pho:​FZD*:​GSK3*:​PAR6*:​RACK1*:​ROR2|​S864_pho|​pho|​pho:​RSPO3:​SYN4*:​VANGL*|​pho|​pho|​pho|​pho:​WGEF*:​WNT*:​_beta_-Arrestin2*@Cytoplasm map → map Angiogenesis@Nucleus map
  2. APC2*:​CK1_epsilon_*:​CTHRC1:​DAAM1:​DVL*|​pho|​S142_pho|​S139_pho:​FZD*:​GSK3*:​PAR6*:​RACK1*:​RHOA:​ROR2|​S864_pho|​pho|​pho:​RSPO3:​SYN4*:​VANGL*|​pho|​pho|​pho|​pho:​WGEF*:​WNT*:​_beta_-Arrestin2*@Cytoplasm map → map APC2*:​CK1_epsilon_*:​CTHRC1:​DAAM1:​DVL*|​pho|​S142_pho|​S139_pho:​FZD*:​GSK3*:​PAR6*:​RACK1*:​ROR2|​S864_pho|​pho|​pho:​RSPO3:​SYN4*:​VANGL*|​pho|​pho|​pho|​pho:​WGEF*:​WNT*:​_beta_-Arrestin2*@Cytoplasm map + RHOA@Cytoplasm map
As Catalyser: